Investigated for treating COVID-19.
- TRADE NAMES: Advantan (Intendis); Medrol (Pharmacia); Solu-Medrol (Pharmacia)
- INDICATIONS: Arthralgias, asthma, dermatoses, inflammatory ocular conditions, rhinitis
- CLASS: Corticosteroid / Glucocorticoid, Corticosteroid, systemic, Covid-19 putative drug, Neuroprotectant
- HALF-LIFE: 12–36 hours; 2–4 hours (plasma)
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aminophylline, Aprepitant, Aspirin, Carbamazepine, Clarithromycin, Conivaptan, Cyclosporine, Daclizumab, Darunavir, Delavirdine, Erythromycin, Indinavir, Itraconazole, Ketoconazole, Live vaccines, Oral Contraceptives, Phenobarbital, Phenytoin, Rifampin, Telaprevir, Telithromycin, Troleandomycin, Voriconazole, Warfarin
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 02/01/2025
